Heritage Insurance Holdings reports Q1 2026 results today with a notable contrast between bullish analyst positioning and a steady stream of insider selling over the past six weeks.
The insider activity is the standout heading into this print. The CEO, CFO-equivalent, and subsidiary president have all been sellers. CEO Ernesto Garateix sold shares twice in April, totalling roughly $230,000 in proceeds. Subsidiary President Timothy Moura sold three tranches in early April worth just under $1.3 million combined. Chief Accounting Officer Sharon Binnun sold in both April and May, adding another $490,000. Net insider activity over the past 90 days runs to approximately $12.4 million in disposals — a meaningful signal of executives taking money off the table as the stock has climbed.
Short interest, by contrast, tells a much quieter story. At 3.5% of free float, the short position has fallen roughly 31% over the past month — from around 1.5 million shares in early April to just over 1 million now. The borrow market is extremely loose: cost to borrow is running near 0.45% annualised, and availability remains ample with the lending pool far from stressed. The ORTEX short score of 38 is comfortably in neutral territory, well below the 52-week high of 43.9 hit on April 23. Shorts are not pressing a thesis here — the retreat in short interest looks more like covering than conviction.
Options positioning is decisively bullish, though not dramatically so. The put/call ratio is 0.175, hugging its 20-day average of 0.171 with a z-score barely above zero. For context, the 52-week high PCR was 0.86 — today's reading is near the bottom of the annual range, reflecting that call volume continues to dominate. The stock itself closed at $28.03, down 2.4% on the day and 4.4% on the week, though it remains up 5.3% over the past month. Peers split on the week: UVE added 2.3% and UFCS surged over 16%, while PGR and SAFT lost ground, leaving HRTG roughly in the middle of the pack.
The analyst community has been consistently constructive. Truist Securities has raised its target three times since mid-2025, most recently to $39 in March — well above the current price of $28. Piper Sandler is at Overweight. Citizens Capital Markets sits at Market Perform. The mean target across coverage is $36.50, implying roughly 30% upside from here. The bull case rests on a $393 million statutory surplus, growing new business, and $203 million in net premiums earned. Bears point to an 8% policy-count decline and flat premiums-in-force of $1.4 billion, flagging customer retention risk and competitive pressure in core markets. The EPS surprise factor score of 82 — near the top of the universe — suggests the company has a track record of beating expectations, which anchors the bull case heading in.
The print will test whether the underlying underwriting momentum can justify the gap between the current share price and where analysts have been steering their targets, even as company insiders have consistently chosen to reduce their own exposure on the way up.
See the live data behind this article on ORTEX.
Open HRTG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
